pCLNDX Retrovirus Expression Vector
Novus Biologicals, part of Bio-Techne | Catalog # NBP2-29539
Product Specifications
Application Notes
The RetroMax system is designed for maximal virus titer in 293 cells. It takes advantages of two properties of 293 cells, i) high level of transfectibility, ii) strong E1A-mediated stimulation of CMV promoter controlled transcription. 293 cells are of nonmurine origin, hence the problem of selective packaging and transfer of VL30 genomes (present in all murine packaging cells) are avoided. Vector supernatants are free of helper virus and are of sufficiently high titer within 2 days of transient transfection in 293 cells to permit infection of more than 50% of dividing target cells in culture.
For amplification, transform DH-5alpha or similar bacteria and plate on LB plates containing 50 ug/ml ampicillin.
For amplification, transform DH-5alpha or similar bacteria and plate on LB plates containing 50 ug/ml ampicillin.
Scientific Data Images for pCLNDX Retrovirus Expression Vector
pCLNDX Retrovirus Expression Vector [NBP2-29539]
pCLNDX Retrovirus Expression Vector [NBP2-29539]
pCLNDX Retrovirus Expression Vector [NBP2-29539]
Formulation, Preparation, and Storage
Formulation
10 ug in 20 ul 1x TE (10 mM Tris, pH 7.5, 1 mM EDTA)
Concentration
Please see the protocols for proper use of this product. If no protocol is available, contact technical services for assistance.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Storage
Store at -20C. Avoid freeze-thaw cycles.
Background: pCLNDX Retrovirus Expression Vector
Alternate Names
pCLNDX, pCLNDX Retrovirus
Additional pCLNDX Retrovirus Expression Vector Products
Product Documents for pCLNDX Retrovirus Expression Vector
Product Specific Notices for pCLNDX Retrovirus Expression Vector
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Support products are guaranteed for 6 months from date of receipt.
Loading...
Loading...
Loading...